705
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Prospects of marine-derived compounds as potential therapeutic agents for glioma

, &
Pages 513-526 | Received 17 Jan 2024, Accepted 17 May 2024, Published online: 12 Jun 2024

References

  • Abdelmohsen UR, Balasubramanian S, Oelschlaeger TA, Grkovic T, Pham NB, Quinn RJ, Hentschel U. 2017. Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections. Lancet Infect Dis. 17(2):e30–e41.
  • Afzal S, Garg S, Ishida Y, Terao K, Kaul SC, Wadhwa R. 2019. Rat glioma cell-based functional characterization of anti-stress and protein deaggregation activities in the marine carotenoids, astaxanthin and fucoxanthin. Mar Drugs. 17(3):189.
  • Alharbi WS, Alshehri AA, Ahmed TA, Md S, Almehmady AM, Alshabibi MA, Altamimi RM, El-Say KM. 2024. Enhancing the antiproliferative activity of perillyl alcohol against glioblastoma cell lines through synergistic formulation with natural oils. Curr Pharm Des. 30(14):1075–1084. doi: 10.2174/0113816128293758240318080527.
  • Alves A, Costa P, Pinto M, Ferreira D, Correia-da-Silva M. 2021. Small molecules of marine origin as potential anti-glioma agents. Molecules. 26(9):2707. doi: 10.3390/molecules26092707.
  • Andersen BM, Faust Akl C, Wheeler MA, Chiocca EA, Reardon DA, Quintana FJ. 2021. Glial and myeloid heterogeneity in the brain tumour microenvironment. Nat Rev Cancer. 21(12):786–802. doi: 10.1038/s41568-021-00397-3.
  • Angom RS, Nakka NMR, Bhattacharya S. 2023. Advances in glioblastoma therapy: an update on current approaches. Brain Sci. 13(11):1536. doi: 10.3390/brainsci13111536.
  • Ayed Y, Bousabbeh M, Mabrouk HB, Morjen M, Marrakchi N, Bacha H. 2012. Impairment of the cell-to-matrix adhesion and cytotoxicity induced by the Mediterranean jellyfish Pelagia noctiluca venom and its fractions in cultured glioblastoma cells. Lipids Health Dis. 11(1):84. doi: 10.1186/1476-511X-11-84.
  • Biegelmeyer R, Schröder R, Rambo DF, Dresch RR, Carraro JLF, Mothes B, Moreira JCF, Junior MLCdF, Henriques AT. 2015. Sphingosines derived from marine sponge as potential multi-target drug related to disorders in cancer development. Mar Drugs. 13(9):5552–5563. doi: 10.3390/md13095552.
  • Binnewerg B, Schubert M, Voronkina A, Muzychka L, Wysokowski M, Petrenko I, Djurovic M, Kovalchuk V, Tsurkan M, Martinovic R, et al. 2020. Marine biomaterials: biomimetic and pharmacological potential of cultivated Aplysina aerophoba marine demosponge. Mater Sci Eng C Mater Biol Appl. 109:110566.
  • Bohringer N, Kramer JC, de la Mora E, Padva L, Wuisan ZG, Liu Y, Kurz M, Marner M, Nguyen H, Amara P, et al. 2023. Genome- and metabolome-guided discovery of marine BamA inhibitors revealed a dedicated darobactin halogenase. Cell Chem Biol. 30:943–952.
  • Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, Giorgi C, Marchi S, Missiroli S, Poletti F, et al. 2012. ATP synthesis and storage. Purinergic Signal. 8:343–357.
  • Cai Q, Li X, Xiong H, Fan H, Gao X, Vemireddy V, Margolis R, Li J, Ge X, Giannotta M, et al. 2023. Optical blood–brain–tumor barrier modulation expands therapeutic options for glioblastoma treatment. Nat Commun. 14(1):4934. doi: 10.1038/s41467-023-40579-1.
  • Chai W, Chen L, Lian XY, Zhang Z. 2018. Anti-glioma efficacy and mechanism of action of tripolinolate A from Tripolium pannonicum. Planta Med. 84(11):786–794. doi: 10.1055/s-0044-101038.
  • Chen L, Chai W, Wang W, Song T, Lian XY, Zhang Z. 2017. Cytotoxic bagremycins from mangrove-derived Streptomyces sp. Q22. J Nat Prod. 80(5):1450–1456. doi: 10.1021/acs.jnatprod.6b01136.
  • Chen LC, Lee WS. 2013. P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo. J Agric Food Chem. 61(11):2811–2819. doi: 10.1021/jf400542m.
  • Chen M, Chai W, Song T, Ma M, Lian XY, Zhang Z. 2018. Anti-glioma natural products downregulating tumor glycolytic enzymes from marine actinomycete Streptomyces sp. ZZ406. Sci Rep. 8(1):72. doi: 10.1038/s41598-017-18484-7.
  • Chen S, Shen H, Zhang P, Cheng H, Dai X, Liu L. 2019. Anti-glioma trichobamide A with an unprecedented tetrahydro-5H-furo[2,3-b]pyrrol-5-one functionality from ascidian-derived fungus Trichobotrys effuse 4729. Chem Commun. 55(10):1438–1441.
  • Chen WL, Turlova E, Sun CL, Kim JS, Huang S, Zhong X, Guan YY, Wang GL, Rutka JT, Feng ZP, et al. 2015. Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways. Mar Drugs. 13(4):2505–2525.
  • Cheng SY, Chen NF, Kuo HM, Yang SN, Sung CS, Sung PJ, Wen ZH, Chen WF. 2018. Prodigiosin stimulates endoplasmic reticulum stress and induces autophagic cell death in glioblastoma cells. Apoptosis. 23(5–6):314–328. doi: 10.1007/s10495-018-1456-9.
  • Cheng YC, Tsao MJ, Chiu CY, Kan PC, Chen Y. 2018. Magnolol inhibits human glioblastoma cell migration by regulating N-cadherin. J Neuropathol Exp Neurol. 77(6):426–436. doi: 10.1093/jnen/nly021.
  • Christgen S, Tweedell RE, Kanneganti TD. 2022. Programming inflammatory cell death for therapy. Pharmacol Ther. 232:108010. doi: 10.1016/j.pharmthera.2021.108010.
  • da Frota MLJr, Braganhol E, Canedo AD, Klamt F, Apel MA, Mothes B, Lerner C, Battastini AM, Henriques AT, Moreira JC. 2009. Extracts of marine sponge Polymastia janeirensis induce oxidative cell death through a caspase-9 apoptotic pathway in human U138MG glioma cell line. Invest New Drugs. 27(5):440–446. doi: 10.1007/s10637-008-9198-0.
  • da Frota MLJr, Braganhol E, Canedo AD, Klamt F, Apel MA, Mothes B, Lerner C, Battastini AM, Henriques AT, Moreira JC. 2009. Brazilian marine sponge Polymastia janeirensis induces apoptotic cell death in human U138MG glioma cell line, but not in a normal cell culture. Invest New Drugs. 27(1):13–20. doi: 10.1007/s10637-008-9134-3.
  • Delello Di Filippo L, Hofstätter Azambuja J, Paes Dutra JA, Tavares Luiz M, Lobato Duarte J, Nicoleti LR, Olalla Saad ST, Chorilli M. 2021. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. Eur J Pharm Biopharm. 168:76–89. doi: 10.1016/j.ejpb.2021.08.011.
  • Edler MC, Fernandez AM, Lassota P, Ireland CM, Barrows LR. 2002. Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the Vinca alkaloids, and dolastatin 10. Biochem Pharmacol. 63(4):707–715.
  • Esposito G, Aiello A, Carbonelli S, Menna M, Fattorusso E, Iuvone T. 2002. Mechanism of cytotoxicity of turbinamide in vitro. Anticancer Res. 22(5):2827–2831.
  • Fang Q. 2024. The versatile attributes of MGMT: its repair mechanism, crosstalk with other DNA repair pathways, and its role in cancer. Cancers. 16(2):331. doi: 10.3390/cancers16020331.
  • Fernandes S, Vieira M, Prudêncio C, Ferraz R. 2024. Betulinic acid for glioblastoma treatment: reality, challenges and perspectives. Int J Mol Sci. 25(4):2108. doi: 10.3390/ijms25042108.
  • Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. 2018. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25(3):486–541. doi: 10.1038/s41418-017-0012-4.
  • Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, Wu Q, Li S, Luo S, Li M, et al. 2022. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I-kappa-B-alpha. Cell Metab. 34:1312–1324.
  • Guo K, Liu Y, Li SH. 2021. The untapped potential of plant sesterterpenoids: chemistry, biological activities and biosynthesis. Nat Prod Rep. 38:2293–2314.
  • Huang HC, Liu WT, Hua KS, Hung HC, Tsai JY, Kuo SC, Huang LJ, Gean PW. 2016. alpha-Carboline derivative TJY-16 inhibits tumor growth by inducing G2/M cell cycle arrest in glioma cells. J Biomed Sci. 23(1):10. doi: 10.1186/s12929-016-0222-y.
  • Iwamaru A, Iwado E, Kondo S, Newman RA, Vera B, Rodríguez AD, Kondo Y. 2007. Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Mol Cancer Ther. 6(1):184–192. doi: 10.1158/1535-7163.MCT-06-0422.
  • Jarry M, Lecointre C, Malleval C, Desrues L, Schouft MT, Lejoncour V, Liger F, Lyvinec G, Joseph B, Loaec N, et al. 2014. Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis. Neuro Oncol. 16(11):1484–1498.
  • Jimenez PC, Wilke DV, Branco PC, Bauermeister A, Rezende-Teixeira P, Gaudencio SP, Costa-Lotufo LV. 2020. Enriching cancer pharmacology with drugs of marine origin. Br J Pharmacol. 177(1):3–27.
  • Karve AS, Desai JM, Gadgil SN, Dave N, Wise-Draper TM, Gudelsky GA, Phoenix TN, DasGupta B, Yogendran L, Sengupta S, et al. 2024. A review of approaches to potentiate the activity of temozolomide against glioblastoma to overcome resistance. Int J Mol Sci. 25:3217.
  • Kasprzak A. 2023. Prognostic biomarkers of cell proliferation in colorectal cancer (CRC): from immunohistochemistry to molecular biology techniques. Cancers. 15(18):4570. doi: 10.3390/cancers15184570.
  • Khotimchenko R, Bryukhovetskiy I, Khotimchenko M, Khotimchenko Y. 2021. Bioactive compounds with antiglioma activity from marine species. Biomedicines. 9(8):886. doi: 10.3390/biomedicines9080886.
  • Kim MC, Cullum R, Machado H, Smith AJ, Yang I, Rodvold JJ, Fenical W. 2019. Photopiperazines A–D, photosensitive interconverting diketopiperazines with significant and selective activity against U87 glioblastoma cells, from a rare, marine-derived actinomycete of the family Streptomycetaceae. J Nat Prod. 82(8):2262–2267.
  • Kocaturk NM, Akkoc Y, Kig C, Bayraktar O, Gozuacik D, Kutlu O. 2019. Autophagy as a molecular target for cancer treatment. Eur J Pharm Sci. 134:116–137. doi: 10.1016/j.ejps.2019.04.011.
  • Kundu M, Das S, Nandi S, Dhara D, Mandal M. 2023. Magnolol and temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition. Biochim Biophys Acta Mol Basis Dis. 1869(7):166782. doi: 10.1016/j.bbadis.2023.166782.
  • Lang F, Liu Y, Chou FJ, Yang C. 2021. Genotoxic therapy and resistance mechanism in gliomas. Pharmacol Ther. 228:107922. doi: 10.1016/j.pharmthera.2021.107922.
  • Lei G, Zhuang L, Gan B. 2022. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 22(7):381–396. doi: 10.1038/s41568-022-00459-0.
  • Li Q, Zhu R, Yi W, Chai W, Zhang Z, Lian XY. 2018. Peniciphenalenins A–F from the culture of a marine-associated fungus Penicillium sp. ZZ901. Phytochemistry. 152:53–60. doi: 10.1016/j.phytochem.2018.04.021.
  • Li W, Xie X, Wu T, Yang H, Peng Y, Luo L, Chen Y. 2020. Targeted delivery of auristatin PE to Hep G2 cells using folate-conjugated boron nitride nanotubes. Mater Sci Eng C Mater Biol Appl. 109:110509.
  • Liang Y, Xie X, Chen L, Yan S, Ye X, Anjum K, Huang H, Lian X, Zhang Z. 2016. Bioactive polycyclic quinones from marine Streptomyces sp. 182SMLY. Mar Drugs. 14(1):10.
  • Liao S, Yuk N, Kim YJ, Xu H, Li X, Wang L, Liu Y, Jung HJ. 2023. Novel terpestacin derivatives with l-amino acid residue as anticancer agents against U87MG-derived glioblastoma stem cells. Bioorg Chem. 132:106392.
  • Liberio MS, Sadowski MC, Nelson CC, Davis RA. 2014. Identification of eusynstyelamide B as a potent cell cycle inhibitor following the generation and screening of an ascidian-derived extract library using a real time cell analyzer. Mar Drugs. 12(10):5222–5239. doi: 10.3390/md12105222.
  • Lin Y, Wu X, Feng S, Jiang G, Luo J, Zhou S, Vrijmoed LL, Jones EB, Krohn K, Steingrover K, et al. 2001. Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. J Org Chem. 66:6252–6256.
  • Martin V, Vale C, Bondu S, Thomas OP, Vieytes MR, Botana LM. 2013. Differential effects of crambescins and crambescidin 816 in voltage-gated sodium, potassium and calcium channels in neurons. Chem Res Toxicol. 26(1):169–178.
  • Martínez-Reyes I, Chandel NS. 2021. Cancer metabolism: looking forward. Nat Rev Cancer. 21(10):669–680. doi: 10.1038/s41568-021-00378-6.
  • Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. 2022. The role of lipids in cancer progression and metastasis. Cell Metab. 34(11):1675–1699. doi: 10.1016/j.cmet.2022.09.023.
  • Mattos DR, Wan X, Serrill JD, Nguyen MH, Humphreys IR, Viollet B, Smith AB3rd, McPhail KL, Ishmael JE. 2022. The marine-derived macrolactone mandelalide A is an indirect activator of AMPK. Mar Drugs. 20(7):418.
  • Medina RA, Goeger DE, Hills P, Mooberry SL, Huang N, Romero LI, Ortega-Barria E, Gerwick WH, McPhail KL. 2008. Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp. J Am Chem Soc. 130:6324–6325.
  • Mizushima N, Komatsu M. 2011. Autophagy: renovation of cells and tissues. Cell. 147(4):728–741. doi: 10.1016/j.cell.2011.10.026.
  • Mohammadi M, Bagheri L, Badreldin A, Fatehi P, Pakzad L, Suntres Z, van Wijnen AJ. 2022. Biological effects of gyrophoric acid and other lichen derived metabolites, on cell proliferation, apoptosis and cell signaling pathways. Chem Biol Interact. 351:109768. doi: 10.1016/j.cbi.2021.109768.
  • Mokarram P, Albokashy M, Zarghooni M, Moosavi MA, Sepehri Z, Chen QM, Hudecki A, Sargazi A, Alizadeh J, Moghadam AR, et al. 2017. New frontiers in the treatment of colorectal cancer: autophagy and the unfolded protein response as promising targets. Autophagy. 13(5):781–819. doi: 10.1080/15548627.2017.1290751.
  • Murugesan M, Kandhavelu M, Thiyagarajan R, Natesan S, Rajendran P, Murugesan A. 2023. Marine halophyte derived polyphenols inhibit glioma cell growth through mitogen-activated protein kinase signaling pathway. Biomed Pharmacother. 159:114288. doi: 10.1016/j.biopha.2023.114288.
  • Nakahata N, Yaginuma T, Ohizumi Y. 1999. Maitotoxin-induced phosphoinositide hydrolysis is dependent on extracellular but not intracellular Ca2+ in human astrocytoma cells. Jpn J Pharmacol. 81(2):240–243. doi: 10.1254/jjp.81.240.
  • Nasrolahi A, Azizidoost S, Radoszkiewicz K, Najafi S, Ghaedrahmati F, Anbiyaee O, Khoshnam SE, Farzaneh M, Uddin S. 2023. Signaling pathways governing glioma cancer stem cells behavior. Cell Signal. 101:110493. doi: 10.1016/j.cellsig.2022.110493.
  • Neupane RP, Parrish SM, Neupane JB, Yoshida WY, Yip MLR, Turkson J, Harper MK, Head JD, Williams PG. 2019. Cytotoxic sesquiterpenoid quinones and quinols, and an 11-membered heterocycle, kauamide, from the Hawaiian marine sponge Dactylospongia elegans. Mar Drugs. 17(7):423.
  • Nguyen HM, Guz-Montgomery K, Lowe DB, Saha D. 2021. Pathogenetic features and current management of glioblastoma. Cancers. 13(4):856. doi: 10.3390/cancers13040856.
  • Norris MD, Perkins MV. 2016. Structural diversity and chemical synthesis of peroxide and peroxide-derived polyketide metabolites from marine sponges. Nat Prod Rep. 33(7):861–880. doi: 10.1039/c5np00142k.
  • Obrador E, Moreno-Murciano P, Oriol-Caballo M, Lopez-Blanch R, Pineda B, Gutierrez-Arroyo JL, Loras A, Gonzalez-Bonet LG, Martinez-Cadenas C, Estrela JM, et al. 2024. Glioblastoma therapy: past, present and future. Int J Mol Sci. 25:2529.
  • Oliveira C, Granja S, Neves NM, Reis RL, Baltazar F, Silva TH, Martins A. 2019. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo. Carbohydr Polym. 223:115034. doi: 10.1016/j.carbpol.2019.115034.
  • Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. 2022. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol. 24(Suppl. 5):v1–v95. doi: 10.1093/neuonc/noac202.
  • Padhy I, Paul P, Sharma T, Banerjee S, Mondal A. 2022. Molecular mechanisms of action of eugenol in cancer: recent trends and advancement. Life. 12(11):1795. doi: 10.3390/life12111795.
  • Peng X, Zhang S, Wang Y, Zhou Z, Yu Z, Zhong Z, Zhang L, Chen ZS, Claret FX, Elkabets M, et al. 2023. Stellettin B sensitizes glioblastoma to DNA-damaging treatments by suppressing PI3K-mediated homologous recombination repair. Adv Sci. 10(3):e2205529.
  • Persano F, Gigli G, Leporatti S. 2022. Natural compounds as promising adjuvant agents in the treatment of gliomas. Int J Mol Sci. 23(6):3360. doi: 10.3390/ijms23063360.
  • Piazzini V, Vasarri M, Degl’Innocenti D, Guastini A, Barletta E, Salvatici MC, Bergonzi MC. 2019. Comparison of chitosan nanoparticles and soluplus micelles to optimize the bioactivity of Posidonia oceanica extract on human neuroblastoma cell migration. Pharmaceutics. 11(12):655. doi: 10.3390/pharmaceutics11120655.
  • Pires HFO, da Silva PR, Dias AL, de Sousa Gomes C, de Sousa NF, Dos Santos AMF, Souza LRP, de Figueiredo Lima JL, Oliveira MCN, Felipe CFB, et al. 2024. Mechanisms involved in the therapeutic effect of cannabinoid compounds on gliomas: a review with experimental approach. Curr Protein Pept Sci. 25(1):27–43.
  • Posor Y, Jang W, Haucke V. 2022. Phosphoinositides as membrane organizers. Nat Rev Mol Cell Biol. 23(12):797–816. doi: 10.1038/s41580-022-00490-x.
  • Pruteanu L-L, Kopanitsa L, Módos D, Kletnieks E, Samarova E, Bender A, Gomez LD, Bailey DS. 2020. Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells. PLOS One. 15(9):e0239551. doi: 10.1371/journal.pone.0239551.
  • Qin L, Yi W, Lian XY, Zhang Z. 2020. Bioactive alkaloids from the Actinomycete Actinoalloteichus sp. ZZ1866. J Nat Prod. 83(9):2686–2695. doi: 10.1021/acs.jnatprod.0c00588.
  • Qin L, Yong K, Lian XY, Zhang Z. 2023. Streptonaphthyridine A, a new naphthyridine analogue with antiproliferative activity against human glioma cells from Mariana trench-associated actinomycete Streptomyces sp. SY2111. Nat Prod Res. 37(3):478–483.
  • Qiu G, Li F, Kowah JAH, Xie J, Long Q, Wang L, Liu X. 2024. Novel chiral matrine derivatives as potential antitumor agents: design, synthesis and biological evaluation. Bioorg Chem. 146:107276. doi: 10.1016/j.bioorg.2024.107276.
  • Ramar V, Guo S, Hudson B, Liu M. 2023. Progress in glioma stem cell research. Cancers. 16(1):102. doi: 10.3390/cancers16010102.
  • Salimi A, Rahimitabar N, Vazirizadeh A, Adhami V, Pourahmad J. 2021. Persian Gulf snail crude venom (Conus textile): a potential source of anti-cancer therapeutic agents for glioblastoma through mitochondrial-mediated apoptosis. Asian Pac J Cancer Prev. 22(S1):49–57. doi: 10.31557/APJCP.2021.22.S1.49.
  • Schaff LR, Mellinghoff IK. 2023. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 329(7):574–587. doi: 10.1001/jama.2023.0023.
  • Schreck KC, Grossman SA, Pratilas CA. 2019. BRAF mutations and the utility of RAF and MEK inhibitors in primary brain tumors. Cancers. 11(9):1262. doi: 10.3390/cancers11091262.
  • Schwartsmann G, Brondani da Rocha A, Berlinck RG, Jimeno J. 2001. Marine organisms as a source of new anticancer agents. Lancet Oncol. 2(4):221–225. doi: 10.1016/s1470-2045(00)00292-8.
  • Serrill JD, Wan X, Hau AM, Jang HS, Coleman DJ, Indra AK, Alani AW, McPhail KL, Ishmael JE. 2016. Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts. Invest New Drugs. 34(1):24–40. doi: 10.1007/s10637-015-0303-x.
  • Sharifzad F, Ghavami S, Verdi J, Mardpour S, Mollapour Sisakht M, Azizi Z, Taghikhani A, Los MJ, Fakharian E, Ebrahimi M, et al. 2019. Glioblastoma cancer stem cell biology: potential theranostic targets. Drug Resist Updat. 42:35–45.
  • Siangcham T, Vivithanaporn P, Sangpairoj K. 2020. Anti-migration and invasion effects of astaxanthin against A172 human glioblastoma cell line. Asian Pac J Cancer Prev. 21(7):2029–2033. doi: 10.31557/APJCP.2020.21.7.2029.
  • Song T, Tang M, Ge H, Chen M, Lian X, Zhang Z. 2019. Novel bioactive penicipyrroether A and pyrrospirone J from the marine-derived Penicillium sp. ZZ380. Mar Drugs. 17(5):292.
  • Sun W, Zhang W, Yu J, Lu Z, Yu J. 2021. Inhibition of Nrf2 might enhance the anti-tumor effect of temozolomide in glioma cells via inhibition of Ras/Raf/MEK signaling pathway. Int J Neurosci. 131:975–983.
  • Tabunoki H, Saito N, Suwanborirux K, Charupant K, Satoh J. 2012. Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids. Cancer Cell Int. 12(1):14. doi: 10.1186/1475-2867-12-14.
  • Tang SA, Zhou Q, Guo WZ, Qiu Y, Wang R, Jin M, Zhang W, Li K, Yamori T, Dan S, et al. 2014. In vitro antitumor activity of stellettin B, a triterpene from marine sponge Jaspis stellifera, on human glioblastoma cancer SF295 cells. Mar Drugs. 12(7):4200–4213.
  • Tang W, Liu ZL, Mai XY, Qi X, Li DH, Gu QQ, Li J. 2020. Identification of gliotoxin isolated from marine fungus as a new pyruvate kinase M2 inhibitor. Biochem Biophys Res Commun. 528(3):594–600. doi: 10.1016/j.bbrc.2020.05.139.
  • Terasaki M, Ikuta M, Kojima H, Tanaka T, Maeda H, Miyashita K, Mutoh M. 2019. Dietary fucoxanthin induces anoikis in colorectal adenocarcinoma by suppressing integrin signaling in a murine colorectal cancer model. J Clin Med. 9(1):90.
  • Tian LW, Feng Y, Shimizu Y, Pfeifer T, Wellington C, Hooper JN, Quinn RJ. 2014. Aplysinellamides A–C, bromotyrosine-derived metabolites from an Australian Aplysinella sp. marine sponge. J Nat Prod. 77(5):1210–1214. doi: 10.1021/np500119e.
  • Tian X, Tang H, Lin H, Cheng G, Wang S, Zhang X. 2013. Saponins: the potential chemotherapeutic agents in pursuing new anti-glioblastoma drugs. Mini Rev Med Chem. 13:1709–1724.
  • Tomar MS, Kumar A, Srivastava C, Shrivastava A. 2021. Elucidating the mechanisms of temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer. 1876(2):188616. doi: 10.1016/j.bbcan.2021.188616.
  • Trisciuoglio D, Uranchimeg B, Cardellina JH, Meragelman TL, Matsunaga S, Fusetani N, Del Bufalo D, Shoemaker RH, Melillo G. 2008. Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide. J Natl Cancer Inst. 100(17):1233–1246. doi: 10.1093/jnci/djn239.
  • Tzitiridou P, Zoi V, Papagrigoriou T, Lazari D, Sioka C, Alexiou GA, Kyritsis AP. 2024. Antineoplastic activity of 9″-lithospermic acid methyl ester in glioblastoma cells. Int J Mol Sci. 25(4):2094. doi: 10.3390/ijms25042094.
  • van Rixel VHS, Ramu V, Auyeung AB, Beztsinna N, Leger DY, Lameijer LN, Hilt ST, Le Devedec SE, Yildiz T, Betancourt T, et al. 2019. Photo-uncaging of a microtubule-targeted rigidin analogue in hypoxic cancer cells and in a xenograft mouse model. J Am Chem Soc. 141:18444–18454.
  • Wätjen W, Ebada SS, Bergermann A, Chovolou Y, Totzke F, Kubbutat MHG, Lin W, Proksch P. 2017. Cytotoxic effects of the anthraquinone derivatives 1′-deoxyrhodoptilometrin and (S)-(−)-rhodoptilometrin isolated from the marine echinoderm Comanthus sp. Arch Toxicol. 91(3):1485–1495. doi: 10.1007/s00204-016-1787-7.
  • Watters DJ. 2018. Ascidian toxins with potential for drug development. Mar Drugs. 16(5):162.
  • Wen ZH, Kuo HM, Shih PC, Hsu LC, Chuang JM, Chen NF, Sun HW, Liu HT, Sung CS, Chen WF. 2023. Isoaaptamine increases ROS levels causing autophagy and mitochondria-mediated apoptosis in glioblastoma multiforme cells. Biomed Pharmacother. 160:114359. doi: 10.1016/j.biopha.2023.114359.
  • Wu Y, Song Y, Wang R, Wang T. 2023. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer. 22(1):96. doi: 10.1186/s12943-023-01801-2.
  • Xie G, Zhu X, Li Q, Gu M, He Z, Wu J, Li J, Lin Y, Li M, She Z, et al. 2010. SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway. Br J Pharmacol. 159(3):689–697.
  • Xie Q, Yang Z, Huang X, Zhang Z, Li J, Ju J, Zhang H, Ma J. 2019. Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway. J Hematol Oncol. 12(1):60. doi: 10.1186/s13045-019-0744-3.
  • Xue Y, Fu Y, Zhao F, Gui G, Li Y, Rivero-Hinojosa S, Liu G, Li Y, Xia S, Eberhart CG, et al. 2021. Frondoside A inhibits an MYC-driven medulloblastoma model derived from human-induced pluripotent stem cells. Mol Cancer Ther. 20(6):1199–1209. doi: 10.1158/1535-7163.MCT-20-0603.
  • Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, et al. 2020. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 5(1):8.
  • Yao Y, Sun S, Cao M, Mao M, He J, Gai Q, Qin Y, Yao X, Lu H, Chen F, et al. 2020. Grincamycin B functions as a potent inhibitor for glioblastoma stem cell via targeting RHOA and PI3K/AKT. ACS Chem Neurosci. 11(15):2256–2265.
  • Ye X, Anjum K, Song T, Wang W, Liang Y, Chen M, Huang H, Lian XY, Zhang Z. 2017. Antiproliferative cyclodepsipeptides from the marine actinomycete Streptomyces sp. P11-23B downregulating the tumor metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis. Phytochemistry. 135:151–159. doi: 10.1016/j.phytochem.2016.12.010.
  • Yi W, Lian XY, Zhang Z. 2022. Cytotoxic metabolites from the marine-associated Streptomyces sp. ZZ1944. Phytochemistry. 201:113292. doi: 10.1016/j.phytochem.2022.113292.
  • Yi W, Newaz AW, Yong K, Ma M, Lian XY, Zhang Z. 2022. New hygrocins K-U and streptophenylpropanamide A and bioactive compounds from the marine-associated Streptomyces sp. ZZ1956. Antibiotics. 11(11):1455. doi: 10.3390/antibiotics11111455.
  • Yong K, Kaleem S, Ma M, Lian X, Zhang Z. 2022. Antiglioma natural products from the marine-associated fungus Penicillium sp. ZZ1750. Molecules. 27(20):7099. doi: 10.3390/molecules27207099.
  • Yong K, Kaleem S, Wu B, Zhang Z. 2021. New antiproliferative compounds against glioma cells from the marine-sourced fungus Penicillium sp. ZZ1750. Mar Drugs. 19(19):483.
  • Yu S, Ye X, Huang H, Peng R, Su Z, Lian XY, Zhang Z. 2015. Bioactive sulfated saponins from sea cucumber Holothuria moebii. Planta Med. 81(2):152–159. doi: 10.1055/s-0034-1383404.
  • Zhang D, Yi W, Ge H, Zhang Z, Wu B. 2019. Bioactive streptoglutarimides A–J from the marine-derived Streptomyces sp. ZZ741. J Nat Prod. 82(10):2800–2808.
  • Zhang D, Yi W, Ge H, Zhang Z, Wu B. 2021. A new antimicrobial indoloditerpene from a marine-sourced fungus aspergillus versicolor ZZ761. Nat Prod Res. 35:3114–3119.
  • Zhang QT, Liu ZD, Wang Z, Wang T, Wang N, Wang N, Zhang B, Zhao YF. 2021. Recent advances in small peptides of marine origin in cancer therapy. Mar Drugs. 19:115.
  • Zhang X, Chen L, Chai W, Lian XY, Zhang Z. 2017. A unique indolizinium alkaloid streptopertusacin A and bioactive bafilomycins from marine-derived Streptomyces sp. HZP-2216E. Phytochemistry. 144:119–126. doi: 10.1016/j.phytochem.2017.09.010.
  • Zhang X, Ye X, Chai W, Lian XY, Zhang Z. 2016. New metabolites and bioactive actinomycins from marine-derived Streptomyces sp. ZZ338. Mar Drugs. 14(10):181.
  • Zhang Z, Chen L, Zhang X, Liang Y, Anjum K, Chen L, Lian XY. 2017. Bioactive bafilomycins and a new N-arylpyrazinone derivative from marine-derived Streptomyces sp. HZP-2216E. Planta Med. 83(18):1405–1411. doi: 10.1055/s-0043-111897.
  • Zheng L, Yi Y, Liu J, Lin X, Yang K, Lv M, Zhou X, Hao J, Liu J, Zheng Y, et al. 2014. Isolation and characterization of marine Brevibacillus sp. S-1 collected from South China Sea and a novel antitumor peptide produced by the strain. PLOS One. 9(11):e111270. doi: 10.1371/journal.pone.0111270.
  • Zhou B, Ji YY, Zhang HJ, Shen L. 2021. Gephyyamycin and cysrabelomycin, two new angucyclinone derivatives from the Streptomyces sp. HN-A124. Nat Prod Res. 35(13):2117–2122. doi: 10.1080/14786419.2019.1660336.
  • Zhou X, Liu J, Yang B, Lin X, Yang XW, Liu Y. 2013. Marine natural products with anti-HIV activities in the last decade. Curr Med Chem. 20:953–973.
  • Zhu Q, Zhou Y, Wang H, Cao T, Wang X, Liu R, Wu H, Lin B. 2023. Fucoxanthin triggers ferroptosis in glioblastoma cells by stabilizing the transferrin receptor. Med Oncol. 40(8):230. doi: 10.1007/s12032-023-02095-6.